Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 36.56190.75-6.18-66.140.22

What is the latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS is 36.56 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar202636.56
Mar2025190.75
Mar2024-6.18
Mar2023-66.14
Mar20220.22

How is EBIT Growth of GLENMARK PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2026 36.56
-80.83
Mar2025 190.75
Positive
Mar2024 -6.18
Negative
Mar2023 -66.14
Negative
Mar2022 0.22 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹67,163.6 Cr -1.5% 5.5% 13.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.5%

5.5%

13.3%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses